{"result": "(\"entity\"<|>DISFAGIA<|>EVENT<|>Disfagia is a clinical symptom characterized by difficulty in swallowing, often associated with various medical conditions, particularly in older adults with neurological disorders.)\n##\n(\"entity\"<|>DOF<|>EVENT<|>Dysphagia oropharyngeal (DOF) is a specific type of swallowing disorder that can lead to aspiration and other complications, particularly in elderly patients.)\n##\n(\"entity\"<|>SISTEMA NACIONAL DE SALUD<|>ORGANIZATION<|>The Sistema Nacional de Salud (SNS) is the national health system in Spain responsible for health data collection and management.)\n##\n(\"entity\"<|>REINO UNIDO<|>GEO<|>The United Kingdom is a country where studies on dysphagia prevalence have been conducted, showing varying rates among the elderly population.)\n##\n(\"entity\"<|>FRANCIA<|>GEO<|>France is another country where studies on dysphagia prevalence have been conducted, with significant findings related to elderly patients.)\n##\n(\"entity\"<|>ALEMANIA<|>GEO<|>Germany is a country where dysphagia prevalence studies have shown lower rates compared to other European countries.)\n##\n(\"entity\"<|>ESPAÑA<|>GEO<|>Spain is a country where dysphagia prevalence studies have indicated a significant percentage of elderly patients experiencing swallowing difficulties.)\n##\n(\"entity\"<|>JAPÓN<|>GEO<|>Japan is a country where studies have reported dysphagia prevalence among elderly patients in the community.)\n##\n(\"entity\"<|>PAÍSES BAJOS<|>GEO<|>The Netherlands is a country where studies have shown dysphagia prevalence among elderly patients.)\n##\n(\"relationship\"<|>DISFAGIA<|>DOF<|>Disfagia is a broader term that encompasses various types of swallowing difficulties, including DOF, which is a specific manifestation of this condition.<|>8)\n##\n(\"relationship\"<|>DOF<|>SISTEMA NACIONAL DE SALUD<|>The Sistema Nacional de Salud (SNS) is responsible for collecting and managing health data related to conditions like DOF, which is crucial for understanding its prevalence.<|>7)\n##\n(\"relationship\"<|>REINO UNIDO<|>DOF<|>Studies in the United Kingdom have reported significant rates of DOF among the elderly population, highlighting its prevalence in this demographic.<|>6)\n##\n(\"relationship\"<|>FRANCIA<|>DOF<|>Research conducted in France has shown high prevalence rates of DOF among elderly patients, indicating a significant public health concern.<|>6)\n##\n(\"relationship\"<|>ALEMANIA<|>DOF<|>Studies in Germany have reported lower prevalence rates of DOF compared to other countries, providing a comparative perspective on the condition.<|>5)\n##\n(\"relationship\"<|>ESPAÑA<|>DOF<|>In Spain, studies have indicated a high prevalence of DOF among the elderly, emphasizing the need for awareness and management strategies.<|>6)\n##\n(\"relationship\"<|>JAPÓN<|>DOF<|>Research in Japan has identified the prevalence of DOF among elderly individuals, contributing to the global understanding of this condition.<|>5)\n##\n(\"relationship\"<|>PAÍSES BAJOS<|>DOF<|>Studies in the Netherlands have reported prevalence rates of DOF among elderly patients, adding to the body of research on this health issue.<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: es un síntoma que, como hemos visto anteriormente, puede aparecer en\n          la evolución de un grupo heterogéneo de patología o asociado al envejecimiento,\n          la sarcopenia, dinapenia y kratopenia. Los signos clínicos más frecuentes que nos\n          alertan de la presencia de DOF son:\n              •   Sensación de ahogo (asfixia) con o sin tos antes, durante o tras tragar.\n              •   Sensación de bolo faríngeo.\n              •   Dificultad para que el alimento progrese por la garganta una vez tragado.\n              •   Calidad de la voz húmeda.\n              •   Cambios en la voz tras la ingesta.\n              Algunos cambios son menos frecuentes, pero nos deben hacer pensar en descar-\n          tar DOF cuando aparecen:\n              •   Babeo.\n              •   Pérdida de peso no intencionada.\n              •   Frecuente carraspeo.\n              •   Cambios en el patrón funcional respiratorio.\n              •   Infecciones respiratorias de repetición.\n              •   Cambios en los hábitos alimentarios.\n              •   Inexplicables picos de fiebre.\n              De todos ellos, merece la pena destacar la tos como signo clínico paradigmático\n          de la DOF. La tos actúa como mecanismo de defensa ante la disfuncionalidad deglu-\n          toria para evitar la aspiración. Sin embargo, en el caso de la disfagia silente, el pa-\n          ciente no presenta tos y serán, por tanto, el resto de signos comentados los que nos\n          deben alertar de la posibilidad de que el paciente presente algún tipo de trastorno\n          de la deglución que condiciona DOF. Estos casos suelen darse en pacientes mayores\n          con enfermedades neurológicas degenerativas, como las que hemos comentado\n          anteriormente, que hacen neumonías de repetición.\n              En estos casos resulta imprescindible profundizar en su estudio mediante prue-\n          bas instrumentales para descartar la presencia de disfagia en ausencia del signo de\n          la tos después de beber o comer. Pero no solo en estos casos, sino que, en todos los\n\n\n\n14\n---\n                                                  1. La disfagia orofaríngea en el siglo xxi, un síntoma ignorado\n\n\n\n    casos, la presencia de cualquiera de los signos clínicos que nos hacen sospechar DOF\n    deberá ratificarse mediante las pruebas de cribado y valoración que comentamos en\n    el segundo capítulo de este manual.\n\n\n\n       6. PREVALENCIA\n\n\n\n        Actualmente, no disponemos de datos globales para conocer la verdadera pre-\n    valencia de la DOF. Las cifras son variables, ya que están condicionadas por distintos\n    factores que afectan a los estudios realizados: ámbito asistencial en el que se practica,\n    las poblaciones estudiadas según patologías (pacientes con ictus, con demencia, con\n    cáncer de cabeza y cuello, etc.), la metodología utilizada en el diagnóstico, e incluso\n    aspectos diferenciales del propio país en donde se realiza el estudio.\n        Este último punto tiene relación con aspectos culturales, de estilo de vida, há-\n    bitos alimentarios, tipo de alimentación o registros de salud, así como con la dis-\n    ponibilidad de conseguir los datos generales en el sistema nacional de salud (SNS)\n    correspondiente.\n        La disfagia es un síntoma relativamente común que ocurre en aproximadamente\n    el 3% de la población general. La codificación es muy relevante en este punto. Así,\n    la estimación de DOF en pacientes admitidos en un hospital por neumonía, puede\n    oscilar entre el 0,35% al 25% según el nivel de codificación realizado.\n        En términos generales, se estima que 1 de cada 17 personas tendrá dificultades\n    para tragar en algún momento de su vida. Según algunos autores, el envejecimiento\n    en sí mismo no es una causa clínicamente significativa22 . Sin embargo, la frecuencia\n    de la DOF aumenta con la edad, de tal forma que entre un 10-30% de los mayores de\n    65 años presenta algún tipo de dificultad en su deglución2  . La DOF está presente en\n    un 55% y 68% de la población anciana institucionalizada, americana y canadiense\n    respectivamente.\n        Las cifras en este colectivo aumentan con la coexistencia de patología, como las\n    descritas en estudios de Reino Unido y Francia, un 79% y 81% respectivamente, algo\n    mayores de las registradas en Alemania, un 43%, y en España un 67%. Además, se\n    han publicado cifras del 11%, 13% y 16% en pacientes mayores en la comunidad en\n    Reino Unido, Japón y Países Bajos respectivamente2  .\n        El 47% de los pacientes que han\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}